# Dexmedetomidine Versus Fentanyl Added to Levobupivacaine for Transversus Abdominis Plane (TAP) Block

> **NCT03778671** · PHASE1,PHASE2 · COMPLETED · sponsor: **Assiut University** · enrollment: 90 (actual)

## Conditions studied

- Transversus Abdominis Block

## Interventions

- **DRUG:** Levobupivacaine
- **DRUG:** Dexmedetomidine Injection [Precedex]
- **DRUG:** fentanyl

## Key facts

- **NCT ID:** NCT03778671
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778671, "Dexmedetomidine Versus Fentanyl Added to Levobupivacaine for Transversus Abdominis Plane (TAP) Block". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03778671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*